function of glp 1 Glucagon-Like Peptide-1 Receptor Agonists–Health Professional Version Unlocking the multifaceted roles of

Furthermore, Feng et al

Alternative diabetes or weight management strategies can be explored if GLP-1 agonists are not suitable for an individual patient

A large study of 2000 patients without diabetes showed that using Ozempic/Wegovy in addition to diet and exercise for 68 weeks led to a 15% weight loss (1/3 of the participants lost up to 20% of their starting weight.) Those in the control group that were only coached on the lifestyle changes lost 2.4% of their weight

Why Product Documentation Should Avoid Performance Claims Product documentation should avoid performance claims because those claims can imply expected outcomes

Supports good health

Drugs are billed separately, using the appropriate HCPCS code